Press Releases
 
Ringworm Treatment Market Key Drivers & On-going Trends 2025

, 15 June 2018 -- The global ringworm treatment market can be segmented based on drug class, route of administration, distribution channel, and region. In terms of drug class, the global market can be categorized into steroids, antifungals, anti-infectives, and others.

Ringworm is a common fungal infection of skin. Tinea is the medical term used for ringworm. The infection is caused by skin fungi called dermatophytes. Ringworm infection can cause scaly, red, and round patches on skin. It can also cause patches of hair loss, itching, blisters, and scaling of scalp. The infection can affect various areas such as skin of scalp, feet, beard, and groin. Ringworm is highly contagious and can be transmitted through animals. The infection can be treated successfully with certain antifungal and over-the-counter medicines.

View Report-

https://www.transparencymarketresearch.com/ringworm-treatment-market.html

The global ringworm treatment market is expected to grow at a rapid pace. High incidence and prevalence of skin disease are the major factors driving the global ringworm treatment market. Increase in prevalence of bacterial and viral infections boosting R&D activities, rise in awareness about antifungal treatment, and novel treatment for diseases also propel the global market. Furthermore, affection toward pets leading to transmission of disease, increase in combination therapies, rise in health care funding, and promising pipeline are anticipated to drive the global ringworm treatment market during the forecast period. However, lack of awareness in some developing countries about antifungal treatment and complication during the regulatory approvals are the factors likely to restrain the global ringworm treatment market during the forecast period.

The global ringworm treatment market can be segmented based on drug class, route of administration, distribution channel, and region. In terms of drug class, the global market can be categorized into steroids, antifungals, anti-infectives, and others.

The antifungals segment is expected to dominate the market during the forecast period due to specificity and effectiveness of the drugs on the infection. Based on route of administration, the global ringworm treatment market can be bifurcated into oral and topical. The topical segment is expected to hold a major share of the global market during the forecast period due to increase in sale of over-the-counter topical medicines for treatment. In terms of distribution channel, the global market can be divided into hospital pharmacies, drug stores, retailers, and e-commerce.

Geographically, the global ringworm treatment market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is projected to dominate the global ringworm treatment market in terms of revenue, followed by Europe. Factors such as rise in incidence of skin diseases, increase in adoption of pets in the region, growth of the health care sector, and increase in awareness drive the ringworm treatment market in the region. Furthermore, the prominent players are focusing on Europe to strengthen their positions.

Request Brochure-

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39386

The market in Asia Pacific is anticipated to expand at the fastest growth rate during the forecast period due to rise in health care expenditure, increase in geriatric population, surge in disposable income, prevalence of chronic diseases, focus of global pharmaceutical companies on Asia Pacific, increase in adoption of exotic pets leading to transmission of the disease, and unhealthy lifestyle in the rural areas.

Key players operating in the global ringworm treatment market have adopted various strategies such as launch of products that are cost effective and efficient, mergers and acquisitions, geographical expansion, and strategic alliance. Prominent players in market are Perrigo Company plc, Novartis AG, GlaxoSmithKline plc, Teva Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd., and Glenmark Pharmaceuticals Inc.

Request For Discount-

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=39386

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email:
Website:www.transparencymarketresearch.com

# # #


Submitted by hawer on Friday, 15 June 2018 at 1:28 PM
Category:
 
Related News

There are no related press releases in this category.

Related Events

There are no related events in this category.

Latest News

css text shadow generator
Wednesday, 15 Aug 2018

Fertility and Pregnancy Rapid Test Kits Market to Expand with Significant CAGR During 2025
Wednesday, 15 Aug 2018

5 Finest Places to Download And Install Android Apps
Tuesday, 14 Aug 2018

Ways to Use Breast Enlargement Cream Successfully
Tuesday, 14 Aug 2018

New Physiocratic League Launches Campaign for the First Georgist Political Party in Decades
Tuesday, 14 Aug 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Wednesday, 15 August 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Federal Dispute Resolution Training 2018
  • SILICON VALLEY FINTECH WEEK 2018
  • Hemophilia Drug Development
  • Data Science Leaders East Coast Network
  • Sydney's Biggest Postgraduate Event - QS World Grad School Tour

  • Latest Jobs
    Sorry, there are currently no entries posted here.